U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06971471) titled 'Artificial Intelligence to Solve the MissINg of Gastric Cancer (AIMING)' on May 06.
Brief Summary: Our AIMING project comprises four core work packages (WPs): WP1. Nation-level randomized controlled trial; WP2. Development of an innovative AI tool; WP3. Novel microsimulation modelling; WP4. Patient inclusion.
The nation-level multi-center tandem randomized controlled trial (WP1) will contribute to a better understanding of how the real-time AI algorithm can reduce miss rate of early gastric cancer and dysplasia during gastroscopy. Moreover, the innovation project will contribute to development of a novel AI tool (WP2) that can strat...